Relying on a consultative approach, deep expertise and decades of experience, we work collaboratively with clients to deliver a successful product launch, program transition or program enhancement. Clients benefit from our market insights, strategic and unique approach and ability to continuously refine our processes.
Generating and Communicating Evidence to Enhance Patient Care and Product Val...Covance
Covance has the expertise to help you overcome the unique challenges of late-phase clinical development. Find out how Covance supports new indications, value communication, adherence strategies, long-term safety and efficacy by reviewing our brochure.
Overcome the unique challenges of late-phase product development and generate the right data to support your products' objective. Products in late-phase development have complex needs and demands. Programs at this phase support new indications, value communication, adherence strategies, safety and efficacy and more.
Top 15 Pharma Gains an Edge in a Highly Competitive Specialty MarketCovance
Due to the complex nature of patient access and reimbursement process for specialty products, the client required a customized hub program to support multiple products, across several therapeutic areas. The unique intricacies of the initiative required a trusted strategic partner who could help advise, inform and support an innovative patient-centric program. In addition to possessing the right expertise and processes, the vendor needed to have a flexible technology platform that could be tailored to support the multiple brand requirements and deliver a seamless experience to various stakeholders including patients, healthcare professionals (HCPs) and specialty pharmacies.
Generating and Communicating Evidence to Enhance Patient Care and Product Val...Covance
Covance has the expertise to help you overcome the unique challenges of late-phase clinical development. Find out how Covance supports new indications, value communication, adherence strategies, long-term safety and efficacy by reviewing our brochure.
Overcome the unique challenges of late-phase product development and generate the right data to support your products' objective. Products in late-phase development have complex needs and demands. Programs at this phase support new indications, value communication, adherence strategies, safety and efficacy and more.
Top 15 Pharma Gains an Edge in a Highly Competitive Specialty MarketCovance
Due to the complex nature of patient access and reimbursement process for specialty products, the client required a customized hub program to support multiple products, across several therapeutic areas. The unique intricacies of the initiative required a trusted strategic partner who could help advise, inform and support an innovative patient-centric program. In addition to possessing the right expertise and processes, the vendor needed to have a flexible technology platform that could be tailored to support the multiple brand requirements and deliver a seamless experience to various stakeholders including patients, healthcare professionals (HCPs) and specialty pharmacies.
From meeting changing healthcare industry demands to
delivering care more collaboratively, you need new ways
to engage your patients and improve productivity. You also
need to streamline patient communications and improve
patient satisfaction, no matter what your specialty or
practice size. NextGen® Patient Portal can help you meet
these goals, safely and securely.
•Identify Key Patient Portal Features and Benefits
•Plan the Implementation and Roll Out of a Patient Portal
•Integrate Patient Portals into Your Practice’s Patient Service Strategy
Putting the Patient First: Launching a Comprehensive Patient-Centric ProgramCovance
Following a successful sponsor/CRO partnership in which Covance supported a large sponsor's reimbursement call center, a solid partnership had formed, founded on trust and a shared culture. The sponsor expanded this partnership with Covance with the desire to seamlessly transition another reimbursement support program from their current vendor. With the additional successful execution of this project, the sponsor selected Covance as their partner to consolidate all existing hub programs, build a tailored customer relationship management (CRM) tool and develop programs focused on the sponsor's specific needs and enhanced new therapeutic areas and markets.
Learn insider tips from industry experts on how to successfully complete your URAC Specialty Pharmacy v3.0 accreditation requirements.*
You’ll walk away with insider knowledge about how to use tools, technology, and lessons learned that specialty pharmacies pay thousands of dollars to access.
How to engage patients to use the patient portal to meet meaningful useFast Track Marketing
Getting patients to engage fully with your patient portal can be hard work but it is a must for meaningful use. If done properly, your portal can not only decrease the time your staff has to spend scheduling appointments, processing paperwork and calling in prescriptions but will give your patients the ability to have some control over their healthcare.
Fast Track Marketing works with practices across the U.S. helping them grow, meet goals and gain efficiency to name a few. One of the areas is this topic: helping them to engage more of their patients with their patient portal.
R2integrated - From Pointing Fingers to PartnershipR2integrated
R2integrated and Loyola University Maryland's presentation at the 2014 AMA Symposium for the Marketing of Higher Education, "From Pointing Fingers to Partnership: An Integrated Approach to Drive Enrollments Goals and Departmental Affection", which highlights how r2i was able to increase enrollment at Loyola by 138% while strengthening the brand and building departmental affection in just 9 short months.
Field Services: Providing On-Site, Field-Based Assistance to Support Customer...Covance
Ensuring access for patients can be complex and impacted by ever-changing factors that require an adaptable and responsive holistic solution to help provider and patients. Relying on a consultative approach, policy expertise and decades of experience, Covance Market Access deploys a variety of different filed-based teams that are tailored to meet your objectives and simplify access for your product.
Field Services: Providing On-Site, Field-Based Assistance to Support Customer...Covance
Ensuring access for patients can be complex and impacted by ever-changing factors that require an adaptable and responsive holistic solution to help provider and patients. Relying on a consultative approach, policy expertise and decades of experience, Covance Market Access deploys a variety of different filed-based teams that are tailored to meet your objectives and simplify access for your product.
From meeting changing healthcare industry demands to
delivering care more collaboratively, you need new ways
to engage your patients and improve productivity. You also
need to streamline patient communications and improve
patient satisfaction, no matter what your specialty or
practice size. NextGen® Patient Portal can help you meet
these goals, safely and securely.
•Identify Key Patient Portal Features and Benefits
•Plan the Implementation and Roll Out of a Patient Portal
•Integrate Patient Portals into Your Practice’s Patient Service Strategy
Putting the Patient First: Launching a Comprehensive Patient-Centric ProgramCovance
Following a successful sponsor/CRO partnership in which Covance supported a large sponsor's reimbursement call center, a solid partnership had formed, founded on trust and a shared culture. The sponsor expanded this partnership with Covance with the desire to seamlessly transition another reimbursement support program from their current vendor. With the additional successful execution of this project, the sponsor selected Covance as their partner to consolidate all existing hub programs, build a tailored customer relationship management (CRM) tool and develop programs focused on the sponsor's specific needs and enhanced new therapeutic areas and markets.
Learn insider tips from industry experts on how to successfully complete your URAC Specialty Pharmacy v3.0 accreditation requirements.*
You’ll walk away with insider knowledge about how to use tools, technology, and lessons learned that specialty pharmacies pay thousands of dollars to access.
How to engage patients to use the patient portal to meet meaningful useFast Track Marketing
Getting patients to engage fully with your patient portal can be hard work but it is a must for meaningful use. If done properly, your portal can not only decrease the time your staff has to spend scheduling appointments, processing paperwork and calling in prescriptions but will give your patients the ability to have some control over their healthcare.
Fast Track Marketing works with practices across the U.S. helping them grow, meet goals and gain efficiency to name a few. One of the areas is this topic: helping them to engage more of their patients with their patient portal.
R2integrated - From Pointing Fingers to PartnershipR2integrated
R2integrated and Loyola University Maryland's presentation at the 2014 AMA Symposium for the Marketing of Higher Education, "From Pointing Fingers to Partnership: An Integrated Approach to Drive Enrollments Goals and Departmental Affection", which highlights how r2i was able to increase enrollment at Loyola by 138% while strengthening the brand and building departmental affection in just 9 short months.
Field Services: Providing On-Site, Field-Based Assistance to Support Customer...Covance
Ensuring access for patients can be complex and impacted by ever-changing factors that require an adaptable and responsive holistic solution to help provider and patients. Relying on a consultative approach, policy expertise and decades of experience, Covance Market Access deploys a variety of different filed-based teams that are tailored to meet your objectives and simplify access for your product.
Field Services: Providing On-Site, Field-Based Assistance to Support Customer...Covance
Ensuring access for patients can be complex and impacted by ever-changing factors that require an adaptable and responsive holistic solution to help provider and patients. Relying on a consultative approach, policy expertise and decades of experience, Covance Market Access deploys a variety of different filed-based teams that are tailored to meet your objectives and simplify access for your product.
You never get a second chance to make a first impression.Endeavor Management
The contact center is the first step in the ideal experience for patients and physicians. In this brief presentation, Gelb will illustrate best practices in contact centers created by national leaders in healthcare. We will examine the differences between functional needs (what must be done) and emotional needs (how patients and physicians feel about your contact center). How does your contact center rate on the 9 Dimensions of call center strategy? Does your contact center engage and enchant callers?
Top 15 Pharma Gains an Edge in a Highly Competitive Specialty MarketCovance
Due to the complex nature of patient access and reimbursement process for specialty products, the client required a customized hub program to support multiple products, across several therapeutic areas. The unique intricacies of the initiative required a trusted strategic partner who could help advise, inform and support an innovative patient-centric program. In addition to possessing the right expertise and processes, the vendor needed to have a flexible technology platform that could be tailored to support the multiple brand requirements and deliver a seamless experience to various stakeholders including patients, healthcare professionals (HCPs) and specialty pharmacies.
Generating and Communicating Evidence to Enhance Patient Care and Product Val...Covance
Late-phase products often have complex needs, requiring clinical research informed by marketing demands. Research at this phase supports new indications, value communication, adherence strategies, long-term safety and efficacy and more. Covance has comprehensive experience in every facet of late-phase research.
We are driven by a passionfor transforming products into brands and patients into survivors. Navicor is a 100% healthcare-focused, full-service agency that understands the unique aspects of the oncology marketplace. We have extensive oncology launch experience and have partnerships with large and small pharma and biotech companies.
The Hub – Solutions Distinctly for Nimble Biotechs Brochure Covance
Welcome to a unique experience - one that's Designed Around You®. Where you control your journey from start to finish. Regardless of where you are and how far you aspire to go, choose the options that make the most of your endeavor. Learn more about the innovations you can tap at any stage of the drug development process.
Advance Your Program in China with Fully Integrated Clinical Development Solu...Covance
Meet your needs for greater efficiency, expanded capacity and customized support at the newly opened Covance Drug Development Center in Shanghai, China.
Genomics Solutions - Single Target to Whole Genome AnalysisCovance
With applied Genomics expertise, global co-location with Central Labs and solutions from biomarker discovery to CDx, our genomics solutions will help make your Precision Medicine drug development a reality.
Medical Device and Diagnostics Solutions for Every Stage of Your Product's De...Covance
Getting a medical device to the patient takes more than good technology in today's environment. Compelling evidence and convincing value proposition matter. Competing priorities and differing stakeholder definitions of value are driving the need for creative, connected strategies to get the most from each step in the development process. And - as evidence is gathered - it should be used to inform and iterate regulatory, reimbursement and clinical post-market strategies.
Pharmacovigilance Risk Management for BiosimilarsCovance
This paper focuses on pharmacovigilance (PV) and risk management for biosimilars, the issues and challenges faced in monitoring their safety and possible solutions.
Cell & Gene Therapy post-approval solutions to reduce scientific, regulatory and commercial risks, and accelerate development wherever you are in your product's development.
Cell & Gene Therapy enterprise development solutions to reduce scientific, regulatory and commercial risks, and accelerate development wherever you are in your product's development.
Cell & Gene Therapy Clinical Development SolutionsCovance
Cell & Gene Therapy clinical development solutions to reduce scientific, regulatory and commercial risks, and accelerate development wherever you are in your product's development.
Inhalation Technology - The Future of Effective Respiratory TreatmentsCovance
Nonclinical development channels: technical strategies, formulations and devices. Conventionally, inhaled drugs have been used to deliver medicines targeted at the most widespread respiratory diseases - specifically, chronic obstructive pulmonary disease (COPD) and asthma.
The Challenges Associated with Evaluating the Cost Benefit of Gene Therapies ...Covance
Despite the growing availability of approved gene therapies, decision-makers face significant challenges when evaluating pricing and reimbursement of these novel therapeutics. From determining cost-benefit ratios, setting out patient access criteria and designing reimbursement plans, this white paper explores some of the complex aspects of value assessment for gene therapies, and discusses results from a survey of key decision-makers across Germany, Sweden and the UK responsible for making pricing and reimbursement decisions.
Environmental Risk Assessment for Pharmaceutical DrugsCovance
Understanding the Evaluation and Implications of Findings to the Regulatory Review of Human Medicines in the Environment. Pharmaceutical drugs are intended for the treatment of human disease, therefore the risk of their environmental exposure in clinical use needs to be evaluated. Environmental risk assessment (ERA) is part of the requirements when applying for marketing approval in many geographic regions throughout the world.
Getting Investigators Onboard: Lab Preferences Make a Difference in Trial Par...Covance
Clinical trials are becoming increasingly complex and competitive, so attracting the best investigator sites to participate in a trial is a crucial step in meeting patient enrollment targets. Learn more about how investigator preference can help meet trial recruitment milestones.
Covance, in partnership with Oracle, offers a full-service, validated, private cloud, single-tenancy solution based on Argus technology, which enables faster and better safety decisions. This automated and integrated solution allows for easy scientific querying and analytics, which improves the quality and efficiency of safety operations. It also enhances compliance with E2B exchange for expedited and periodic reporting, allowing the organization to conduct global case processing, which can scale to tens of thousands of annual cases.
Plant Metabolism Studies: Options for Plant CultivationCovance
Regulators across the world are concerned with ensuring that any residues left in or on a crop after application of a plant protection product (PPP), present minimal risk to the health of humans and animals. To achieve this, regulators need information on the identity of the residues and the levels of residues remaining in or on a crop, in order to assess dietary risk and set maximum residue levels (MRLs). The testing approaches used are harmonized across most countries worldwide, focusing on the Organization for Economic Co-operation and Development (OECD) Test Guidelines (TGs) for pesticide residue chemistry. This e-book paper focuses on the laboratory-based plant cultivation methods that underlie the success of OECD crop metabolism studies, namely TG 501 and 502.
K-REACH - How to Prepare for the K-REACH LegislationCovance
In 2015, South Korea introduced legislation designed to protect human health and the environment from the impact of chemicals. The two pieces of legislation introduced were the: Act on the Registration and Evaluation of Chemicals (K-REACH), which mandates the registration of all new and existing chemicals marketed or imported into South Korea at ≥1 metric ton per year, requiring detailed information on their likely hazard to human health and the environment and the Chemicals Control Act (CCA), which focuses on chemical reporting and chemical accident prevention.
US Toxic Substances Control Act (TSCA) ReformCovance
The Toxic Substances Control Act (TSCA) Public Law 94-469, was first signed into Law on October 11, 1976 due to the use of a large number of chemicals in the United States (US) and exposure to human health or the environment. This act was recently updated under 'The Frank R. Lautenberg Chemical Safety for the 21st Century Act', Public Law 114-182, and was signed into Law on June 22, 2016 by US President Obama. The scope of the reform does not include; pesticides, tobacco, nuclear materials, food, drugs or cosmetics. TSCA allows the Environmental Protection Agency (EPA) to assess chemical risks to human health and the environment and to take action to control these risks. In summary, TSCA authorizes the EPA to keep an 'inventory' of all existing chemicals. Currently the inventory comprises approximately 83,000 chemicals that are being manufactured or imported into the US. Chemicals on the inventory can be manufactured or imported into the US, chemicals that are not on the inventory cannot be manufactured or imported into the US.
Neonicotinoids: The Science and Regulatory ComplexityCovance
List of pharmacology models and assays. Includes core battery, supplemental safety assessment, add-ons for toxicology studies, efficacy models, GLP microbiology (cell-based assays), supplemental microbiology/virology and supplemental add-ons to tox/pharmacology studies, GMP testing and inhalation delivery tests for crop and chemical toxicology and pharmacology.
New Product Registration - Key Considerations when Registering New ProductsCovance
The regulation related to the Registration, Evaluation, Authorization and Restriction of Chemicals (REACH) was adopted by the EU in 2007 in response to worldwide initiatives to address the impact of chemicals on human health and the environment. REACH requires all manufacturers and importers of chemicals into European markets to assess and manage the risks associated with their substances and products, and register them with the European Chemicals Agency (ECHA). To manage this project, ECHA split existing substances into three categories, based on the amount of the substance that is used annually, with different registration deadlines for different tonnages of use.
Phase I Hybrid Trials: A Guide to Successful Planning and ExecutionCovance
Phase I hybrid trials are early clinical studies combining both healthy normal volunteers (HNVs) and patients from the target indication in one protocol. These trials can be extraordinarily valuable, as they can deliver important insights regarding a drug's pharmacodynamic (PD) effects and therapeutic potential at a very early stage in development. This white paper provides an overview of hybrid trial background and feasibility, and discusses considerations around potential value, study design options, biomarker strategies and regulatory aspects with a few case studies to illustrate the successful execution of hybrid studies.
The prostate is an exocrine gland of the male mammalian reproductive system
It is a walnut-sized gland that forms part of the male reproductive system and is located in front of the rectum and just below the urinary bladder
Function is to store and secrete a clear, slightly alkaline fluid that constitutes 10-30% of the volume of the seminal fluid that along with the spermatozoa, constitutes semen
A healthy human prostate measures (4cm-vertical, by 3cm-horizontal, 2cm ant-post ).
It surrounds the urethra just below the urinary bladder. It has anterior, median, posterior and two lateral lobes
It’s work is regulated by androgens which are responsible for male sex characteristics
Generalised disease of the prostate due to hormonal derangement which leads to non malignant enlargement of the gland (increase in the number of epithelial cells and stromal tissue)to cause compression of the urethra leading to symptoms (LUTS
Title: Sense of Taste
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the structure and function of taste buds.
Describe the relationship between the taste threshold and taste index of common substances.
Explain the chemical basis and signal transduction of taste perception for each type of primary taste sensation.
Recognize different abnormalities of taste perception and their causes.
Key Topics:
Significance of Taste Sensation:
Differentiation between pleasant and harmful food
Influence on behavior
Selection of food based on metabolic needs
Receptors of Taste:
Taste buds on the tongue
Influence of sense of smell, texture of food, and pain stimulation (e.g., by pepper)
Primary and Secondary Taste Sensations:
Primary taste sensations: Sweet, Sour, Salty, Bitter, Umami
Chemical basis and signal transduction mechanisms for each taste
Taste Threshold and Index:
Taste threshold values for Sweet (sucrose), Salty (NaCl), Sour (HCl), and Bitter (Quinine)
Taste index relationship: Inversely proportional to taste threshold
Taste Blindness:
Inability to taste certain substances, particularly thiourea compounds
Example: Phenylthiocarbamide
Structure and Function of Taste Buds:
Composition: Epithelial cells, Sustentacular/Supporting cells, Taste cells, Basal cells
Features: Taste pores, Taste hairs/microvilli, and Taste nerve fibers
Location of Taste Buds:
Found in papillae of the tongue (Fungiform, Circumvallate, Foliate)
Also present on the palate, tonsillar pillars, epiglottis, and proximal esophagus
Mechanism of Taste Stimulation:
Interaction of taste substances with receptors on microvilli
Signal transduction pathways for Umami, Sweet, Bitter, Sour, and Salty tastes
Taste Sensitivity and Adaptation:
Decrease in sensitivity with age
Rapid adaptation of taste sensation
Role of Saliva in Taste:
Dissolution of tastants to reach receptors
Washing away the stimulus
Taste Preferences and Aversions:
Mechanisms behind taste preference and aversion
Influence of receptors and neural pathways
Impact of Sensory Nerve Damage:
Degeneration of taste buds if the sensory nerve fiber is cut
Abnormalities of Taste Detection:
Conditions: Ageusia, Hypogeusia, Dysgeusia (parageusia)
Causes: Nerve damage, neurological disorders, infections, poor oral hygiene, adverse drug effects, deficiencies, aging, tobacco use, altered neurotransmitter levels
Neurotransmitters and Taste Threshold:
Effects of serotonin (5-HT) and norepinephrine (NE) on taste sensitivity
Supertasters:
25% of the population with heightened sensitivity to taste, especially bitterness
Increased number of fungiform papillae
Title: Sense of Smell
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the primary categories of smells and the concept of odor blindness.
Explain the structure and location of the olfactory membrane and mucosa, including the types and roles of cells involved in olfaction.
Describe the pathway and mechanisms of olfactory signal transmission from the olfactory receptors to the brain.
Illustrate the biochemical cascade triggered by odorant binding to olfactory receptors, including the role of G-proteins and second messengers in generating an action potential.
Identify different types of olfactory disorders such as anosmia, hyposmia, hyperosmia, and dysosmia, including their potential causes.
Key Topics:
Olfactory Genes:
3% of the human genome accounts for olfactory genes.
400 genes for odorant receptors.
Olfactory Membrane:
Located in the superior part of the nasal cavity.
Medially: Folds downward along the superior septum.
Laterally: Folds over the superior turbinate and upper surface of the middle turbinate.
Total surface area: 5-10 square centimeters.
Olfactory Mucosa:
Olfactory Cells: Bipolar nerve cells derived from the CNS (100 million), with 4-25 olfactory cilia per cell.
Sustentacular Cells: Produce mucus and maintain ionic and molecular environment.
Basal Cells: Replace worn-out olfactory cells with an average lifespan of 1-2 months.
Bowman’s Gland: Secretes mucus.
Stimulation of Olfactory Cells:
Odorant dissolves in mucus and attaches to receptors on olfactory cilia.
Involves a cascade effect through G-proteins and second messengers, leading to depolarization and action potential generation in the olfactory nerve.
Quality of a Good Odorant:
Small (3-20 Carbon atoms), volatile, water-soluble, and lipid-soluble.
Facilitated by odorant-binding proteins in mucus.
Membrane Potential and Action Potential:
Resting membrane potential: -55mV.
Action potential frequency in the olfactory nerve increases with odorant strength.
Adaptation Towards the Sense of Smell:
Rapid adaptation within the first second, with further slow adaptation.
Psychological adaptation greater than receptor adaptation, involving feedback inhibition from the central nervous system.
Primary Sensations of Smell:
Camphoraceous, Musky, Floral, Pepperminty, Ethereal, Pungent, Putrid.
Odor Detection Threshold:
Examples: Hydrogen sulfide (0.0005 ppm), Methyl-mercaptan (0.002 ppm).
Some toxic substances are odorless at lethal concentrations.
Characteristics of Smell:
Odor blindness for single substances due to lack of appropriate receptor protein.
Behavioral and emotional influences of smell.
Transmission of Olfactory Signals:
From olfactory cells to glomeruli in the olfactory bulb, involving lateral inhibition.
Primitive, less old, and new olfactory systems with different path
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists Saeid Safari
Preoperative Management of Patients on GLP-1 Receptor Agonists like Ozempic and Semiglutide
ASA GUIDELINE
NYSORA Guideline
2 Case Reports of Gastric Ultrasound
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?bkling
Are you curious about what’s new in cervical cancer research or unsure what the findings mean? Join Dr. Emily Ko, a gynecologic oncologist at Penn Medicine, to learn about the latest updates from the Society of Gynecologic Oncology (SGO) 2024 Annual Meeting on Women’s Cancer. Dr. Ko will discuss what the research presented at the conference means for you and answer your questions about the new developments.
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...VarunMahajani
Disruption of blood supply to lung alveoli due to blockage of one or more pulmonary blood vessels is called as Pulmonary thromboembolism. In this presentation we will discuss its causes, types and its management in depth.
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdfAnujkumaranit
Artificial intelligence (AI) refers to the simulation of human intelligence processes by machines, especially computer systems. It encompasses tasks such as learning, reasoning, problem-solving, perception, and language understanding. AI technologies are revolutionizing various fields, from healthcare to finance, by enabling machines to perform tasks that typically require human intelligence.
263778731218 Abortion Clinic /Pills In Harare ,sisternakatoto
263778731218 Abortion Clinic /Pills In Harare ,ABORTION WOMEN’S CLINIC +27730423979 IN women clinic we believe that every woman should be able to make choices in her pregnancy. Our job is to provide compassionate care, safety,affordable and confidential services. That’s why we have won the trust from all generations of women all over the world. we use non surgical method(Abortion pills) to terminate…Dr.LISA +27730423979women Clinic is committed to providing the highest quality of obstetrical and gynecological care to women of all ages. Our dedicated staff aim to treat each patient and her health concerns with compassion and respect.Our dedicated group ABORTION WOMEN’S CLINIC +27730423979 IN women clinic we believe that every woman should be able to make choices in her pregnancy. Our job is to provide compassionate care, safety,affordable and confidential services. That’s why we have won the trust from all generations of women all over the world. we use non surgical method(Abortion pills) to terminate…Dr.LISA +27730423979women Clinic is committed to providing the highest quality of obstetrical and gynecological care to women of all ages. Our dedicated staff aim to treat each patient and her health concerns with compassion and respect.Our dedicated group of receptionists, nurses, and physicians have worked together as a teamof receptionists, nurses, and physicians have worked together as a team wwww.lisywomensclinic.co.za/
NVBDCP.pptx Nation vector borne disease control programSapna Thakur
NVBDCP was launched in 2003-2004 . Vector-Borne Disease: Disease that results from an infection transmitted to humans and other animals by blood-feeding arthropods, such as mosquitoes, ticks, and fleas. Examples of vector-borne diseases include Dengue fever, West Nile Virus, Lyme disease, and malaria.
Flu Vaccine Alert in Bangalore Karnatakaaddon Scans
As flu season approaches, health officials in Bangalore, Karnataka, are urging residents to get their flu vaccinations. The seasonal flu, while common, can lead to severe health complications, particularly for vulnerable populations such as young children, the elderly, and those with underlying health conditions.
Dr. Vidisha Kumari, a leading epidemiologist in Bangalore, emphasizes the importance of getting vaccinated. "The flu vaccine is our best defense against the influenza virus. It not only protects individuals but also helps prevent the spread of the virus in our communities," he says.
This year, the flu season is expected to coincide with a potential increase in other respiratory illnesses. The Karnataka Health Department has launched an awareness campaign highlighting the significance of flu vaccinations. They have set up multiple vaccination centers across Bangalore, making it convenient for residents to receive their shots.
To encourage widespread vaccination, the government is also collaborating with local schools, workplaces, and community centers to facilitate vaccination drives. Special attention is being given to ensuring that the vaccine is accessible to all, including marginalized communities who may have limited access to healthcare.
Residents are reminded that the flu vaccine is safe and effective. Common side effects are mild and may include soreness at the injection site, mild fever, or muscle aches. These side effects are generally short-lived and far less severe than the flu itself.
Healthcare providers are also stressing the importance of continuing COVID-19 precautions. Wearing masks, practicing good hand hygiene, and maintaining social distancing are still crucial, especially in crowded places.
Protect yourself and your loved ones by getting vaccinated. Together, we can help keep Bangalore healthy and safe this flu season. For more information on vaccination centers and schedules, residents can visit the Karnataka Health Department’s official website or follow their social media pages.
Stay informed, stay safe, and get your flu shot today!
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Optimizing Each Patient's Product Access Experience
1. OPTIMIZING EACH
PATIENT’S PRODUCT
ACCESS EXPERIENCE
▶▶ Access & StrategyAccess & Strategy
▶ Evidence Generation
▶ Value Communications
▶ Phase IV Solutions
▶ Patient Support
▶ Field Services
▶ Patient Safety
2. FORWARD-THINKING
SOLUTIONS FOR
PATIENT SUPPORT
Covance manages end-to-end contact
center programs that focus on your
customers’ needs, ensuring they have
the information and support they
need to overcome access barriers.
Relying on a consultative approach, deep expertise and
decades of experience, we work collaboratively with clients
to deliver a successful product launch, program transition
or program enhancement. Clients benefit from our market
insights, strategic and unique approach and ability to
continuously refine our processes.
Delivering high-quality service to patients and healthcare
practitioners is instrumental in ensuring patient access and
supporting adherence to critical treatments. Our mission is
to improve patient outcomes and satisfaction while
providing actionable insights to support our clients' brands.
30+ years
of hub experience
1,000+
products
25+
therapeutic areas
50+
manufacturers
3. Covance programs are led by expert program directors and
executed by seasoned teams operating in multiple regional call centers
staffed by over 1,500 highly trained customer service individuals.
Turn to our experts for an
informed, methodical, strategic
approach to designing,
implementing and operating
successful patient support
programs.
Patient-centric
case management
Insurance-related
support services
Billing, coding and claims
assistance for healthcare providers
Non-commercial prescription
fulfillment via Covance Specialty
Pharmacy
Cost-sharing support
Administration of patient assistance programs
for the under-insured and uninsured
Clinical and nursing
support
Data aggregation and
analytics
Opt-in and enrollment
Specialty pharmacy
coordination and support
Intake and enrollment
Patient insurance education and advocacy
Evaluation of pharmacy options
Specialty pharmacy coordination
Financial assessment
Benefits verification
Prior authorization (PA) support
Assistance with appeals (PA and claim denials)
Insurance counseling and referrals
Coverage and reimbursement information
Coding research and support
Claims review and tracking
Triage and coordination among pharmacies
Physician communication
Education on financial resources
Evaluation, enrollment and referrals
to copayment assistance programs or
independent foundations
Screening and eligibility evaluation
Enrollment and re-enrollment
Fulfillment for short-term supply programs
Fulfillment and refills for free drug programs
Pharmacist services
Disease education
Adherence support
Clinician education
Clinical trial recruitment and education
360° view of patient journey
Turn-key data solution
Broad data sets producing actionable insights
Specialty pharmacy channel partner data
Opt-in programs for educational programs
Program materials and guides
Provider referral
▶
▶
▶
▶
▶
▶
▶
▶
▶
▶
▶
▶
▶
▶
▶
▶
▶
▶
▶
▶
▶
▶
▶
▶
▶
▶
▶
▶
▶
▶
▶
▶
1,500
360º view of patient journey